Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage
about
Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System DisordersCuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damageProtective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating diseaseLeukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory diseaseDevelopment of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditionsActivated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions.The novel synthetic microneurotrophin BNN27 protects mature oligodendrocytes against cuprizone-induced death, through the NGF receptor TrkA.Anticonvulsive Effects of Licofelone on Status Epilepticus Induced by Lithium-pilocarpine in Wistar Rats: a Role for Inducible Nitric Oxide Synthase.The benefits and detriments of macrophages/microglia in models of multiple sclerosisCysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.A new model of cuprizone-mediated demyelination/remyelination.Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12/IL-17/IL-11 axis and restriction of mature oligodendrocytes apoptosis.Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.
P2860
Q28278005-0FA53F6F-A9F0-4A98-BF29-1C5B761C0D52Q30442608-DAED2847-2EA2-462D-93FA-11E0E3F96CFFQ33828361-77D2AA2C-D677-43F6-99E7-B743B4FEE5DDQ33922879-9299CEA0-45E3-4AAF-997F-53C3F58BDF9FQ34532441-0C4C8F35-5BA7-452A-94ED-9A1B9136149DQ36133389-0CA86451-6F5B-4E79-8257-CB70BF91042AQ36269130-ECE4A5A4-D225-4628-A8DD-917552B1EB35Q36388390-BDF623D3-C887-4586-A1BE-399A470CF1FEQ37548964-02161777-ACEC-4752-9B7F-F8216BB33DB0Q38120527-30323CB8-DF5F-4CA9-94E5-545518104D3AQ38728679-D31989A3-12D6-47CA-8D60-0256106F33BAQ41761293-B3243263-03CE-4D40-8AD8-8B24B6A41A31Q44448576-4B8B4CDA-243A-4D07-935D-5C9CCAFD94F3Q48107365-9B58CD7D-46F4-4FB2-8CAA-6AE8C214A1BBQ50202910-7D13C6C5-0A90-4512-9535-1744A3E69C24Q50441333-2D81AD04-D60B-40FD-99D4-6EC9BBF94A51Q52338686-3D623344-F0BE-4758-A02F-3D27673F230E
P2860
Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhibition of 5-lipoxygenase a ...... dysfunction and axonal damage
@ast
Inhibition of 5-lipoxygenase a ...... dysfunction and axonal damage
@en
type
label
Inhibition of 5-lipoxygenase a ...... dysfunction and axonal damage
@ast
Inhibition of 5-lipoxygenase a ...... dysfunction and axonal damage
@en
prefLabel
Inhibition of 5-lipoxygenase a ...... dysfunction and axonal damage
@ast
Inhibition of 5-lipoxygenase a ...... dysfunction and axonal damage
@en
P2093
P2860
P1476
Inhibition of 5-lipoxygenase a ...... dysfunction and axonal damage
@en
P2093
C D Toscano
K Yoshikawa
P2860
P356
10.1016/J.PLEFA.2011.04.022
P577
2011-05-08T00:00:00Z